A Clinical Study of MK-1084 With Other Treatments for Non-small Cell Lung Cancer (MK-3475-01F)

Clinical trial NCT07286149 · RECRUITING

Trial details

NCT number: NCT07286149
Sponsor: Merck Sharp & Dohme LLC
Status: RECRUITING
Phase: Phase 1, Phase 2
Study type: INTERVENTIONAL

Lung Neoplasm Malignant

Start date: 2026-04-30
Primary completion: 2029-08-17
Enrollment: 140

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.